Sonoma Pharmaceuticals Inc (SNOA)
0.159
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
0.1602
0.00 (0.00%)
After-Hours: 20:00
Sonoma Pharmaceuticals Shareholders Equity (Quarterly): 6.692M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.692M |
September 30, 2023 | 5.675M |
June 30, 2023 | 7.242M |
March 31, 2023 | 7.977M |
December 31, 2022 | 5.559M |
September 30, 2022 | 7.021M |
June 30, 2022 | 7.959M |
March 31, 2022 | 8.697M |
December 31, 2021 | 11.17M |
September 30, 2021 | 11.46M |
June 30, 2021 | 4.621M |
March 31, 2021 | 5.363M |
December 31, 2020 | 12.32M |
September 30, 2020 | 11.56M |
June 30, 2020 | 11.41M |
March 31, 2020 | 5.624M |
December 31, 2019 | 11.21M |
September 30, 2019 | 10.27M |
June 30, 2019 | 11.50M |
March 31, 2019 | 10.49M |
December 31, 2018 | 13.34M |
September 30, 2018 | 10.78M |
June 30, 2018 | 12.63M |
March 31, 2018 | 15.33M |
December 31, 2017 | 14.26M |
Date | Value |
---|---|
September 30, 2017 | 16.16M |
June 30, 2017 | 18.61M |
March 31, 2017 | 21.43M |
December 31, 2016 | 22.86M |
September 30, 2016 | 6.039M |
June 30, 2016 | 7.75M |
March 31, 2016 | 10.14M |
December 31, 2015 | 9.118M |
September 30, 2015 | 10.75M |
June 30, 2015 | 11.14M |
March 31, 2015 | 12.05M |
December 31, 2014 | 7.828M |
September 30, 2014 | 13.37M |
June 30, 2014 | 13.40M |
March 31, 2014 | 12.06M |
December 31, 2013 | 3.397M |
September 30, 2013 | 1.55M |
June 30, 2013 | 2.617M |
March 31, 2013 | 4.081M |
December 31, 2012 | 3.128M |
September 30, 2012 | -0.501M |
June 30, 2012 | 0.342M |
March 31, 2012 | -0.868M |
December 31, 2011 | 0.163M |
September 30, 2011 | -0.136M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.621M
Minimum
Jun 2021
12.32M
Maximum
Dec 2020
8.596M
Average
7.977M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 39.70M |
Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 14.62M |
Total Liabilities (Quarterly) | 7.926M |
Debt to Equity Ratio | 0.0066 |
Current Ratio | 4.067 |
Net Debt Paydown Yield | 1.62% |